Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Wolozin, Benjamin | Person |
Why?
|
| McKee, Ann | Person |
Why?
|
| Ikezu, Tsuneya | Person |
Why?
|
| Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in TauP301L-BiFC mice. | Academic Article |
Why?
|
| Visualization of soluble tau oligomers in TauP301L-BiFC transgenic mice demonstrates the progression of tauopathy. | Academic Article |
Why?
|
| Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1. | Academic Article |
Why?
|
| Alosco, Michael | Person |
Why?
|
| Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity. | Academic Article |
Why?
|
| Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice. | Academic Article |
Why?
|
| TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau. | Academic Article |
Why?
|
| Stein, Thor | Person |
Why?
|
| Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy. | Academic Article |
Why?
|
| Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo. | Academic Article |
Why?
|
| RNA binding proteins co-localize with small tau inclusions in tauopathy. | Academic Article |
Why?
|
| Tau Protein Hyperphosphorylation and Aggregation in Alzheimer''s Disease and Other Tauopathies, and Possible Neuroprotective Strategies. | Academic Article |
Why?
|